Bayer halts Xarelto trial
Trial was evaluating the drug in patients with embolic stroke of undetermined source (ESUS). - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/bayer_halts_xarelto_trial_1207036Trial was evaluating the drug in patients with embolic stroke of undetermined source (ESUS). - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/bayer_halts_xarelto_trial_1207036Shire is reportedly in advanced talks to acquire Baxter's biopharma spin-off Baxalta and may announce a deal this week. - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/shire_and_baxalta_near_deal_1020698Appointment boosts healthcare offering - Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/lansons_recruits_kate_aldous_1029021CRO hopes partnership will accelerate drugs' time to market - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/medidata_teams_with_pharm-olam_1256852Vaccine uses T-cells to potentially attack multiple strains of the virus - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/universal_flu_vaccine_to_be_tested_1206771London-based agency begins trading today - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/method_medical_media_launches_1204334Drug is only darunavir-based STR indicated for HIV-1 infection in adults and adolescents - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/ec_approves_janssens_symtuza_1206421If approved by the FDA, this would mark the third indication for Keytruda in metastatic NSCLC in the United States based on OS data - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/fda_grants_keytruda_priority_review_1233852Rejection is another win for drugs' originator Roche - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/novartis_biosimilar_rituximab_delayed_in_us_1234248Drug becomes the first oral therapy and Janus kinase (JAK) inhibitor available for UC - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/pfizers_xeljanz_cleared_for_ulcerative_colitis_in_europe_1246474